

QIAGEN
"Provider of molecular diagnostics and Sample to Insight solutions for life sciences."
About QIAGEN
QIAGEN develops Sample to Insight solutions that transform biological samples into actionable molecular insights. The company serves over 500,000 customers worldwide with products spanning nucleic acid purification, digital PCR, next generation sequencing, and syndromic testing. From tuberculosis management to cancer diagnostics, QIAGEN's technologies enable scientists to advance precision medicine and improve patient outcomes. Founded in 1984, QIAGEN operates across 25 countries with 5,700 people representing 75 nationalities. The portfolio includes over 500 core products and integrated automation systems. QIAGEN combines scientific rigour with sustainability commitments, including validated net zero targets and eco-designed products.


5700
Team Members
1984
Founded
Public
Funding
Hybrid
Work Environment
A world where molecular insights accelerate scientific breakthroughs, improve healthcare outcomes, and enable precision medicine to reach every patient who needs it.
At QIAGEN, our mission is to enable customers worldwide to advance science, improve patient outcomes, and gain valuable insights from biological samples.